Research Article
Retrospective Study of Aging and Sex-Specific Risk Factors of COVID-19 with Hypertension in China
Table 7
Risk factors associated with female COVID-19 patients with hypertension.
| | Univariable OR (95% CI) | p Value | Multivariable OR (95% CI) | p Value |
| | Alanine aminotransferase, IU/L | 0.98 (0.957–1.003) | 0.092 | | | | Aspartate aminotransferase, IU/L | 0.949 (0.906–0.995) | 0.031 | | | | Total bile acid, umol/L | | | | | | <0.1 | 0.852 (0.534–1.361) | 0.033 | | | | 0.1–10 | 1 (ref) | – | | | | >10 | 1.895 (0.568–3.308) | 0.033 | 4.611 (0.469–7.778) | 0.029 | | Total protein, g/L | 0.955 (0.916–0.996) | 0.03 | 0.677 (0.544–0.990) | 0.036 | | Globulin, g/L | 0.91 (0.846–0.98) | 0.012 | | | | Total bilirubin, umol/L | | | | | | <5.13 | 1.08(0.417–2.789) | 0.874 | | | | 5.13–22.24 | 1 (ref) | – | | | | >22.24 | 1.06 (0.99–1.136) | 0.094 | | | | Indirect bilirubin, umol/L | 1.033 (0.996–1.073) | 0.084 | | | | Low-density lipoprotein, mmol/L | 0.552 (0.282–1.083) | 0.084 | 0.319 (0.117–0.872) | 0.026 | | Urea/Creatinine | 0.976 (0.956–0.996) | 0.019 | | | | Glucose, mmol/L | 0.743 (0.05–1.002) | 0.052 | | | | Lymphocyte count, ×109 per L | 0.897 (0.809–1.699) | 0.059 | | | | <0.8 | 1.071 (0.003–1.616) | 0.097 | | | | 0.8–4 | 1 (ref) | – | | | | >4 | – | – | | | | Monocyte count, ×109 per L | 1.472 (0.989–2.19) | 0.057 | | | | Red blood cell distribution width SD, fL | 0.915 (0.828–1.012) | 0.083 | | | | <35 | 0.362 (0.177–0.742) | 0.005 | | | | 35–56 | 1 (ref) | – | | | | >56 | 0.634 (0.279–1.438) | 0.275 | | | | Mean hemoglobin, pg | 0.645 (0.422–0.985) | 0.042 | 0.905 (0.872–0.939) | 0.037 | | Thrombin time>18, s | 1.748 (0.95–3.216) | 0.073 | | | | Fibrinogen, g/L | 0.603 (0.342–1.061) | 0.079 | | |
|
|
